Giant cell tumour of bone in the rib cage treated with denosumab. A case report

被引:0
|
作者
Miralles, Paula Serret [1 ]
Fernandez, Ruth Orellana [1 ]
Parente, Tamara Parra [1 ]
Brigido, Rosa Belen Garcia-Chamon [1 ]
Salas, Ruben Carrera [1 ]
机构
[1] Univ Autonoma Barcelona, Parc Tauli Hosp Univ, Inst Invest Parc Tauli I3PT, Serv Patol, Sabadell, Spain
来源
REVISTA ESPANOLA DE PATOLOGIA | 2023年 / 56卷 / 02期
关键词
Giant cell tumour of bone; Denosumab;
D O I
10.1016/j.patol.2021.04.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Giant cell tumour of bone (GCTOB) accounts for 4-5% of all primary bone tumours and occurs most frequently in females between 20 and 45 years old. It is found in the epiphyses of the long bones, vertebral bodies and flat bones. We report the case of a 31-year-old woman who presented with a one month history of thoracic pain. On examination, a mass was found in the right breast with signs of an ipsilateral pleural effusion. A thoracic CAT scan revealed an infiltrating mass which was subsequently biopsied and a GCTOB was diagnosed. Due to the localization and the morphology, a wide range of differential diagnoses were considered. Genetic studies detected a mutation of the gene H3F3A, supporting the original diagnosis. The patient underwent treatment with denosumab followed by surgical resection of the mass. The histopathology of the tumour revealed various histological changes which were a source of diagnostic pitfalls. (c) 2021 Sociedad Espanola de Anatom<acute accent>& imath;a Patolo<acute accent>gica. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Denosumab: a breakthrough in treatment of giant-cell tumour of bone?
    Balke, Maurice
    Hardes, Jendrik
    LANCET ONCOLOGY, 2010, 11 (03): : 218 - 219
  • [22] The current standing on the use of denosumab in giant cell tumour of the bone
    Singh, Vivek Ajit
    Puri, Ajay
    JOURNAL OF ORTHOPAEDIC SURGERY, 2020, 28 (03)
  • [23] Safety and efficacy of denosumab in giant-cell tumour of bone
    Kyrgidis, Athanassios
    Toulis, Konstantinos
    LANCET ONCOLOGY, 2010, 11 (06): : 513 - 514
  • [24] SAFETY AND EFFICACY OF DENOSUMAB IN GIANT CELL TUMOUR OF BONE (GCTB)
    Thomas, D.
    Blay, J. Y.
    Chawla, S.
    Broto, J. M.
    Choy, E.
    Dominkus, M.
    Engellau, J.
    Grimer, R.
    Henshaw, R.
    Palmerini, E.
    Reichardt, P.
    Rutkowski, P.
    Skubitz, K.
    Zhao, Y.
    Qian, Y.
    Jacobs, I.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S558 - S558
  • [25] A recurrent giant cell tumor of bone treated with denosumab
    Stadler, Nicola
    Fingernagel, Thomas
    Hofstaetter, Stefan G.
    Trieb, Klemens
    CLINICS AND PRACTICE, 2015, 5 (01)
  • [26] Giant-cell tumour of the sphenoid bone: Case report
    Rimmelin, A
    Roth, T
    George, B
    Dias, P
    Clouet, PL
    Dietemann, JL
    NEURORADIOLOGY, 1996, 38 (07) : 650 - 653
  • [27] Osteonecrosis of the jaw in a patient on Denosumab. A case report.
    Cornil, Celine
    Ilisei, Dragos
    Kafi, Sophia Abdel
    Vandemergel, Xavier
    ACTA CLINICA BELGICA, 2014, 69 : S6 - S6
  • [28] Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery
    von Borstel, Donald
    Taguibao, Roberto A.
    Strle, Nicholas A.
    Burns, Joseph E.
    SKELETAL RADIOLOGY, 2017, 46 (04) : 571 - 578
  • [29] The role of Denosumab in joint preservation for patients with giant cell tumour of bone
    Perrin, D. L.
    Visgauss, J. D.
    Wilson, D. A.
    Griffin, A. M.
    Razak, A. R. Abdul
    Ferguson, P. C.
    Wunder, J. S.
    BONE & JOINT JOURNAL, 2021, 103B (01): : 184 - 191
  • [30] Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery
    Donald von Borstel
    Roberto A. Taguibao
    Nicholas A. Strle
    Joseph E. Burns
    Skeletal Radiology, 2017, 46 : 571 - 578